Aardvark Therapeutics Inc (AARD) returns
Aardvark Therapeutics returns over 1 year
$1,000 invested in Aardvark Therapeutics one year ago was worth $130.02 at the close on October 30, 2026, with dividends reinvested. The same $1,000 in the S&P 500 (SPY) became $1,124.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -74.2% | — | $258.07 | -0.9% |
| 3 months | -78.8% | — | $212.50 | +2.1% |
| Year to date | -89.6% | — | $103.62 | +11.7% |
| 1 year | -87.0% | — | $130.02 | +12.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Aardvark Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.